Pancreatic Enzyme Replacement Market Report 2026

Pancreatic Enzyme Replacement Market Overview

• Pancreatic Enzyme Replacement market size has reached to $5.25 billion in 2025 • Expected to grow to $7.54 billion in 2030 at a compound annual growth rate (CAGR) of 7.5% • Growth Driver: Rising Incidence Of Gastrointestinal Diseases Is Fueling The Market Growth Due To Increasing Need For Digestive Support Solutions • Market Trend: Impact Of Delayed-Release Capsules On Exocrine Pancreatic Insufficiency (EPI) • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Pancreatic Enzyme Replacement Market?

Pancreatic enzyme replacement is a treatment for patients with insufficient pancreatic enzyme production. It involves synthetic enzymes, such as amylase, lipase, and protease, to help digest carbohydrates, fats, and proteins. These enzymes are released in the small intestine, breaking down macronutrients into absorbable molecules, improving nutrient absorption, and alleviating symptoms of malnutrition and weight loss in individuals with pancreatic insufficiency. The main product types of pancreatic enzyme replacement therapy include tablets, capsules, powders, and others. Pancreatic enzyme replacement tablets are oral medications designed to aid digestion by supplying essential enzymes to individuals with pancreatic insufficiency. The enzymes are derived from various sources, including porcine-derived, microbial-derived, and recombinant-derived enzymes, and are used for applications such as chronic pancreatitis, cystic fibrosis, pancreatic cancer, and others. They are distributed through hospital pharmacies, retail pharmacies, online pharmacies, and others, catering to end users, including hospitals, clinics, and home healthcare settings.

What Is The Pancreatic Enzyme Replacement Market Growth Forecast?

The pancreatic enzyme replacement market size is expected to see strong growth in the next few years. It will grow to $7.54 billion in 2030 at a compound annual growth rate (CAGR) of 7.5%. The growth in the forecast period can be attributed to increasing use of microbial and recombinant-derived enzymes, growth in chronic pancreatitis and cystic fibrosis patient base, expansion of home healthcare services, rise in oral and delayed-release formulations, integration of digital monitoring and dosage optimization. Major trends in the forecast period include increasing adoption of personalized enzyme therapy, integration of ai for dosage optimization, growth of oral powder and capsule formulations, rising demand for home healthcare enzyme solutions, expansion of hospital and clinic distribution channels.

Global Pancreatic Enzyme Replacement Market Segmentation

1) By Product Type: Tablets, Capsules, Powders, Other Product Types 2) By Source Of Enzymes: Porcine-Derived Enzymes, Microbial-Derived Enzymes, Recombinant-Derived Enzymes 3) By Application: Chronic Pancreatitis, Cystic Fibrosis, Pancreatic Cancer, Other Applications 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels 5) By End-User: Hospitals, Clinics, Home Healthcare Subsegments: 1) By Tablets: Film-Coated Tablets, Chewable Tablets, Extended-Release Tablets 2) By Capsules: Gel Capsules, Liquid-Filled Capsules, Delayed-Release Capsules 3) By Powders: Oral Powder, Sachets 4) By Other Product Types: Enzyme Suspensions, Oral Solutions

What Is The Driver Of The Pancreatic Enzyme Replacement Market?

The rising incidence of gastrointestinal diseases is expected to propel the growth of the pancreatic enzyme replacement market going forward. Gastrointestinal diseases are disorders that affect the digestive tract, including the esophagus, stomach, intestines, liver, pancreas, and gallbladder, leading to symptoms such as abdominal pain, bloating, diarrhea, and constipation. The rising incidence of gastrointestinal diseases is primarily due to poor dietary habits, as increasing consumption of processed foods, low fiber intake, and high-fat diets can disrupt gut health and lead to conditions such as acid reflux, irritable bowel syndrome, and inflammatory bowel disease. Pancreatic enzyme replacement helps gastrointestinal diseases by improving nutrient absorption and digestion, thereby alleviating symptoms such as malnutrition, bloating, and steatorrhea commonly associated with pancreatic insufficiency. For instance, in December 2023, according to the IBD Registry, a UK-based non-profit organization, the number of individuals with inflammatory bowel disease (IBD) surpassed 5,300, reflecting an increase of over 3,000 members compared to 2022. Therefore, the rising incidence of gastrointestinal diseases is driving the growth of the pancreatic enzyme replacement industry.

Key Players In The Global Pancreatic Enzyme Replacement Market

Major companies operating in the pancreatic enzyme replacement market are Johnson & Johnson, Abbott Laboratories, Viatris Inc., Nestlé Health Science S.A., Chiesi Farmaceutici S.p.A., Now Health Group Inc., AzurRx BioPharma Inc., Nordmark Arzneimittel GmbH & Co. KG, Alcresta Therapeutics Inc., Perseo Pharma AG, Digestive Care Inc., Anagram Therapeutics Inc., Entero Therapeutics Inc., Sun Pharmaceutical Industries Ltd, Laboratoires Mayoly Spindler, Recordati S.p.A., Synmosa Biopharma Corporation, Dr Falk Pharma GmbH, Enzymedica Inc., VIVUS Inc., Pharming Group NV, Dr Reddy’s Laboratories, Teva Pharmaceutical Industries Ltd, AstraZeneca plc, Bausch Health Companies Inc

Global Pancreatic Enzyme Replacement Market Trends and Insights

Major companies operating in the pancreatic enzyme replacement market are focusing on developing innovative formulations such as delayed-release capsules to improve enzyme stability and enhance therapeutic efficacy for patients with pancreatic insufficiency. Delayed-release capsules are designed to release their contents at a specific time or location in the digestive tract, helping pancreatic enzyme replacement by ensuring the enzymes are released in the small intestine, where they can aid in digestion while bypassing the stomach's acidic environment that would degrade them. For instance, in March 2025, Adalvo Limited, a Malta-based pharmaceutical manufacturing company, launched its Pancreatin Delayed-Release Capsules, designed to enhance enzyme stability and improve the therapeutic efficacy for patients with exocrine pancreatic insufficiency (EPI). These capsules are specifically formulated to release their contents in the small intestine, where pancreatic enzymes can effectively aid in digestion, while bypassing the stomach's acidic environment that would otherwise degrade them. This innovation aims to address a critical need for patients suffering from conditions such as chronic pancreatitis, cystic fibrosis, and pancreatectomy.

What Are Latest Mergers And Acquisitions In The Pancreatic Enzyme Replacement Market?

In December 2023, Nestlé Health Science S.A., a Switzerland-based nutritional science company, acquired CDX-7108 from Codexis Inc. for $45 million. With this acquisition, Nestlé Health Science aims to advance the development and commercialization of CDX-7108, an investigational therapy designed to overcome the limitations of traditional pancreatic enzyme replacement therapy for exocrine pancreatic insufficiency, with Codexis enabling Nestlé Health Science to continue its clinical trials and bring the therapy to market. Codexis Inc. is a US-based protein engineering company that developed a lipase variant called CDX-7108 for the treatment of exocrine pancreatic insufficiency (EPI) using pancreatic enzyme replacement therapy (PERT).

Regional Outlook

North America was the largest region in the pancreatic enzyme replacement market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Pancreatic Enzyme Replacement Market?

The pancreatic enzyme replacement market consists of revenues earned by entities by providing services such as enzyme supplementation, personalized treatment plans, patient education and support, and ongoing monitoring and follow-up care. The market value includes the value of related goods sold by the service provider or included within the service offering. The pancreatic enzyme replacement market also includes sales of creon, zenpep, pancreaze, ultresa, and pertzye. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Pancreatic Enzyme Replacement Market Report 2026?

The pancreatic enzyme replacement market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the pancreatic enzyme replacement industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.